Professor Hasan Al Farhan

Professor Hasan Al Farhan

Iraqi Board for Medical Specializations, Baghdad (Iraq)

Member of:

Prof Hasan Al-Farhan, FESC, FACC, FRCPE, FHFA, FECVI, FSCAI, is a Senior Consultant Cardiologist, Medical Educationalist, President of Iraqi Scientific Council of Cardiology, the President of ICOS-Iraq Chapter, Affiliated Member of the Study Group on PPCM, Supervisor of the National Program of Heart Disease in Pregnancy, the Head of Baghdad Cardio-Maternal Unit, and the National Coordinator of the EORP in Iraq, including PPCM with it’s sub-study of PPCM Biomarker, ROPAC II and III, Acute Coronary Syndrome – STEMI, NSTEMI and HF3 registries. Al-Farhan is a member of the steering committee of ACS-STEMI Registry. Also he is a reviewer in the international journal of Annals of Internal Medicine. Al-Farhan has a wide experience in researches, audits, and clinical trials [a member in the writing committee of EASY Trial, National Leader of INTERACT trial], and his in interest focus on; HF, heart disease in pregnancy, and ACS. He was the President of Iraq Cardiothoracic Society 2013-2015.

Presentations Articles

Role of the cardiology pharmacist in improving quality of care for patients with acute myocardial infarction based on ESC-ACCA quality indicators

Event: ESC Congress 2024

Topic: Allied Professions in Cardiovascular Care

Session: Innovative approaches to delivering cardiovascular care

Access

Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Clinical heart failure from diagnostics to treatment

Access

Predictors of outcomes for patients with CTRCD using 2022 ESC quality indicators: data from first cardio-oncology clinic in Iraq

Event: Heart Failure 2023

Topic: Cardio-Oncology

Session: Cardiovascular disease in special poopulations - cardio-oncology

Access

Coronary angiographic profile in non ST elevation acute coronary syndrome: risk stratification and management strategy

Event: ESC Preventive Cardiology 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Moderated ePoster 9

Access

International Registry of Cardiovascular diseases in Women (IROCW): Assessing the feasibility of large data registry in absence of funding and electronic database; initial data from Iraq

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Disease in Women

Session: Moderated ePoster 6

Access

Subsequent pregnancies in patients with history of peripartum cardiomyopathy: impact on left ventricular ejection fraction and global longitudinal strain

Event: Heart Failure 2021

Topic: Pregnancy and Cardiovascular Disease

Session: ePoster session

Access

Non-compaction cardiomyopathy and pregnancy: clinical characteristics and outcomes

Event: Heart Failure 2021

Topic: Pregnancy and Cardiovascular Disease

Session: ePoster session

Access

Evaluate the role of LV GLS in detection the impact of time from diagnosis to initiation of chemotherapy on development of subclinical dysfunction in patients with Hodgkin lymphoma

Event: Heart Failure 2021

Topic: Cardio-Oncology

Session: ePoster session

Access

Assessment of left ventricular function in patients with atrial fibrillation using real time triplain speckle tracking in comparison with 2D speckle tracking

Event: EuroEcho 2019

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging

Access

Role of cardiac resynchronization therapy in optimizing the recovery of left ventricular function in a patient with peripartum cardiomyopathy and left bundle branch block

Event: Heart Failure 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Clinical Cases

Access

ESC 365 is supported by

Explore sponsored resources

Professor Hasan Al Farhan

Biography

Contributor content

Role of the cardiology pharmacist in improving quality of care for patients with acute myocardial infarction based on ESC-ACCA quality indicators

Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction

Predictors of outcomes for patients with CTRCD using 2022 ESC quality indicators: data from first cardio-oncology clinic in Iraq

Coronary angiographic profile in non ST elevation acute coronary syndrome: risk stratification and management strategy

International Registry of Cardiovascular diseases in Women (IROCW): Assessing the feasibility of large data registry in absence of funding and electronic database; initial data from Iraq

Subsequent pregnancies in patients with history of peripartum cardiomyopathy: impact on left ventricular ejection fraction and global longitudinal strain

Non-compaction cardiomyopathy and pregnancy: clinical characteristics and outcomes

Evaluate the role of LV GLS in detection the impact of time from diagnosis to initiation of chemotherapy on development of subclinical dysfunction in patients with Hodgkin lymphoma

Assessment of left ventricular function in patients with atrial fibrillation using real time triplain speckle tracking in comparison with 2D speckle tracking

Role of cardiac resynchronization therapy in optimizing the recovery of left ventricular function in a patient with peripartum cardiomyopathy and left bundle branch block

ESC 365 is supported by

Professor Hasan Al Farhan Follow

Biography

Contributor content

Role of the cardiology pharmacist in improving quality of care for patients with acute myocardial infarction based on ESC-ACCA quality indicators

Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction

Predictors of outcomes for patients with CTRCD using 2022 ESC quality indicators: data from first cardio-oncology clinic in Iraq

Coronary angiographic profile in non ST elevation acute coronary syndrome: risk stratification and management strategy

International Registry of Cardiovascular diseases in Women (IROCW): Assessing the feasibility of large data registry in absence of funding and electronic database; initial data from Iraq

Subsequent pregnancies in patients with history of peripartum cardiomyopathy: impact on left ventricular ejection fraction and global longitudinal strain

Non-compaction cardiomyopathy and pregnancy: clinical characteristics and outcomes

Evaluate the role of LV GLS in detection the impact of time from diagnosis to initiation of chemotherapy on development of subclinical dysfunction in patients with Hodgkin lymphoma

Assessment of left ventricular function in patients with atrial fibrillation using real time triplain speckle tracking in comparison with 2D speckle tracking

Role of cardiac resynchronization therapy in optimizing the recovery of left ventricular function in a patient with peripartum cardiomyopathy and left bundle branch block

ESC 365 is supported by

Professor Hasan Al Farhan